Ransomware Resilience for Pipeline Operators
International Journal of Engineering & Extended Technologies Research · 04.04.2024 · 06 (02)
DOI: 10.15662/ijeetr.2024.0602010 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Engineering & Extended Technologies Research, online erschienen am 04.04.2024. Verfasst von Vilas Shewale.
Abstract (Originalsprache)
The Colonial Pipeline breach in May 2021 effectively rendered ransomware against pipeline operators a real concern. In the 3 years since the breach, BlackCat, LockBit, the CL0P group with their MOVEit data theft exploit, Play Ransomware and Akira Ransomware, amongst others, have all attacked pipeline operators. Simultaneously, authorities such as the TSA have issued new requirements and the SEC's cyber disclosure ruling took effect in December 2023. This paper investigates the nature of the ransomware threat today, the anatomy of a ransomware incident impacting a pipeline and outlines an architecture of defense-in-depth based on five essential capabilities: Prevention, Limitation, Detection, Response and Recovery. Finally, it addresses critical issues affecting pipeline ransomware incident response: reliance on manual operational procedures, the decision-maker responsible for ransom payment and the regulatory compliance and reporting deadlines imposed in parallel to incident response activities
Zitieren
APA
Shewale, V. (2024). Ransomware Resilience for Pipeline Operators. International Journal of Engineering & Extended Technologies Research, 06(02). https://doi.org/10.15662/ijeetr.2024.0602010
Vancouver
Shewale V. Ransomware Resilience for Pipeline Operators. International Journal of Engineering & Extended Technologies Research. 2024;06(02). doi:10.15662/ijeetr.2024.0602010
BibTeX
@article{Shewale2024,
author = {Shewale, Vilas},
title = {Ransomware Resilience for Pipeline Operators},
journal = {International Journal of Engineering & Extended Technologies Research},
year = {2024},
volume = {06},
number = {02},
doi = {10.15662/ijeetr.2024.0602010}
}
EUVIMED